Teva Pharmaceuticals

💰 $100.0m Post-IPO Equity on 2023-11-13🫂 on 2022-07-01PharmaceuticalBiopharmaMedicalHealth Care
Website LinkedIn Email Phone # Facebook Twitter

Teva Pharmaceuticals is a pharmaceutical company specializing in the development, production, and marketing of generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients.